Cardiogen is a short peptide characterized as a bioregulator with distinctive properties centered around fibroblasts, cells considered responsible for tissue repair and scar formation. Although initially studied for its involvement in various cardiovascular diseases,...
Comprised of 39 amino acids, Tirzepatide, a synthetic analog of the gastric inhibitory polypeptide (GIP), stands as a comparatively large peptide that appears to exert physiological potential through targeting and binding to GIP and GLP-1 (glucagon-like peptide-1)...
ACE-031 peptide is a soluble form of the type IIB activin receptor (ACVR2B), studied for its potential regulatory action on muscle growth. ACE-031 research suggests that the compound may have an extensive role in binding with and subsequently inactivating myostatin, a...
Liraglutide belongs to the glucagon-like peptide-1 receptor agonists (GLP-1 RAs) class and is primarily researched for its potential influence in weight and insulin secretion. Researchers suggest Liraglutide peptide may enhance glucose-dependent insulin secretion from...
B7-33 is a single-chain peptide, synthesized in a soluble form and derived from the naturally occurring protein H2-relaxin. This peptide appears to retain the anti-fibrotic properties of relaxin, reportedly without increasing cAMP production. B7-33 studies have...
ARA-290 is a synthetic 11-amino acid peptide developed to mimic erythropoietin’s structure and function (EPO). This hormone is considered to be a production regulator of red blood cells.(1) ARA-290 peptide is a non-erythropoietic peptide that researchers suggest...
